Episurf Medical announces that the surgery of the 100th Episealer® implant in Germany will take place in the coming weeks.
“There is currently great activity around the Episealer® knee implants in the German market. Several German clinics have initiated marketing activities where they use the Episealer® as a proof of being at the forefront of novel knee cartilage treatments. This is of course of great help for our market acceptance. We would like to thank all the clinics working with us at this early stage, as we jointly work towards helping a large group of patients back to living life“ says Pål Ryfors, CEO of Episurf Medical.
In total, more than 250 patients have been treated with the Episealer® knee implantat.
For more information, please contact:
Pål Ryfors, CEO, Episurf Medical
Tel:+46 (0) 709 62 36 69
About Episurf Medical
Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and personalized treatment alternatives. Episurf Medical’s Episealer® personalized implants and Epiguide® surgical drill guides are developed for treating localized cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.
This information is information that Episurf Medical AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 14.00 CET on 11 December 2017.